About this paper
Design of experiment (DOE) was utilized to optimize a peptide microarray to test autoantibodies in serum against various components of the myelin sheath. Incorporating the ideal assay conditions from a single DOE experiment versus multiple sequential experiments resulted in a reproducible serum assay with low variability, low nonspecific background, and a high level of distinction between multiple sclerosis (MS) and normal samples. A minimum set of peptides was found that achieved a sensitivity of 90 percent. Autoantibodies against each individual peptide were elevated in at least 35 percent of the individual MS patients tested.
Acerca de SAS
SAS es líder en Analytics. A través de innovadoras soluciones de Analytics, Gestión de Datos y Business Intelligence, SAS ayuda a clientes en más de 83.000 instalaciones a tomar mejores decisiones más rápidamente. Desde 1976, SAS proporciona a sus clientes en todo el mundo THE POWER TO KNOW®
¿Tiene un Perfil SAS? Para completar este formulario automáticamente Acceso Perfil